Please use a PC Browser to access Register-Tadawul
Did Signs of Slowing Demand and Weak Backlog Just Shift Flowserve's (FLS) Investment Narrative?
Flowserve Corporation FLS | 65.54 65.54 | -0.12% 0.00% Pre |
- In recent days, Flowserve reported signs of slowing demand alongside weak backlog growth and limited free cash flow margin, prompting questions about its financial flexibility.
- This development may affect the company's ability to invest in growth initiatives or return capital to shareholders moving forward.
- We'll explore how concerns about weaker backlog growth and cash flow margins could impact Flowserve's long-term investment narrative.
AI is about to change healthcare. These 33 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.
Flowserve Investment Narrative Recap
To hold Flowserve shares, you need to believe in the company's ability to capitalize on long-term flow control demand, especially in energy transition and water infrastructure. The recent news of slowing demand, weak backlog growth, and tighter free cash flow margins raises concerns about Flowserve's near-term investment flexibility, which is now a more prominent risk. Any material impact on future margin expansion or capital returns could weigh on the biggest short-term catalyst for the stock: continued improvements in project execution and earnings leverage.
Among recent developments, Flowserve’s revised 2025 guidance, cutting its organic sales growth outlook to 3-4%, stands out as most relevant. This more cautious growth target, coming alongside concerns about backlog and cash flow, tempers short-term expectations just as investors weigh the significance of large project bookings and ongoing efficiency gains.
Yet, in contrast to past periods of backlog resilience, investors should be aware that...
Flowserve's outlook anticipates $5.3 billion in revenue and $620.7 million in earnings by 2028. This reflects a 4.4% annual revenue growth rate and a $329 million increase in earnings from the current $291.6 million.
Uncover how Flowserve's forecasts yield a $66.50 fair value, a 32% upside to its current price.
Exploring Other Perspectives
Eight distinct fair value estimates from the Simply Wall St Community range from US$42.14 to US$163.51, underscoring broad differences in outlook. Shifting backlog and demand conditions may test whether Flowserve continues to capture the industry tailwinds underpinning these varied projections; examining several viewpoints could be essential before forming your own.
Explore 8 other fair value estimates on Flowserve - why the stock might be worth 17% less than the current price!
Build Your Own Flowserve Narrative
Disagree with existing narratives? Create your own in under 3 minutes - extraordinary investment returns rarely come from following the herd.
- A great starting point for your Flowserve research is our analysis highlighting 6 key rewards and 1 important warning sign that could impact your investment decision.
- Our free Flowserve research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate Flowserve's overall financial health at a glance.
Looking For Alternative Opportunities?
Every day counts. These free picks are already gaining attention. See them before the crowd does:
- The latest GPUs need a type of rare earth metal called Terbium and there are only 39 companies in the world exploring or producing it. Find the list for free.
- Explore 26 top quantum computing companies leading the revolution in next-gen technology and shaping the future with breakthroughs in quantum algorithms, superconducting qubits, and cutting-edge research.
- Trump has pledged to "unleash" American oil and gas and these 22 US stocks have developments that are poised to benefit.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.


